1.Effect of Core Stability Training on Motor of Upper Limbs after Stroke
Jianshe ZHANG ; Dongmei CHANG ; Junqing WANG ; Yujiao SUN ; Yinxing ZHU ; Yongquan TANG ; Qunqiang WU
Chinese Journal of Rehabilitation Theory and Practice 2012;18(11):1008-1010
Objective To explore the effect of core stability training (CST) on motor of upper limbs after stroke. Methods 60 patients with stroke were divided into observation group (n=30) and control group (n=30). Both groups accepted routine medicine and motor relearning program, and the observation group accepted CST before training. They were assessed with Simple Test for Evaluating Hand Function (STEF), modified Barthel index (MBI), and the Trunk Control Test (TCT) before and 4 weeks after treatment. Results The scores of STEF,MBI, and TCT improved after treatment in both groups (P<0.01), and improved more in the observation group than in the control group (P<0.01). Conclusion CST may facilitate the motor recovery of upper limbs after stroke.
2.Application and discussion of teaching model of Team-based learning teaching integrated with evi-dence-based medicine introduced clinical case in Type 2 diabetes mellitus clinical training
Yi BAO ; Haiyan CHEN ; Liangliang SUN ; Wei TANG ; Jiaoyang ZHENG ; Junjie ZOU ; Yongquan SHI
Chinese Journal of Medical Education Research 2017;16(9):935-938
The knowledge of endocrine metabolic diseases represented by type 2 diabetes mellitus is highly specialized, complicated, and has many clinical guidelines. In this context, team based learning teaching combined with case teaching based on evidence-based medicine was applied in the actual class teaching. The class was divided into several groups and the students were encouraged to discuss and study from each other with the guidance of teachers. Consequently, students' learning interests and spirit of team-work were greatly enhanced, the way of thinking using evidence-based medicine and their ability to solve the practical clinical problems were also improved.
3.Content of recombinant human hepatocyte growth factor naked plasmid expression product and its antigenicity in the human body
Peng CHEN ; Yuqin WANG ; Yongquan GU ; Shijun CUI ; Dayou DING ; Xiaochuang TANG
International Journal of Surgery 2010;37(3):155-158,封3
Objective Study the concentration of the hepatocyte growth factor(HGF) the expression product of recombinant human hepatocyte growth factor naked plasmid ,and whether the body generates immune responseafter wsing HCF. Methods Selected 21 patients with severe ischemic disease of lower extremity (Rutherford classification 4-6 class) , after signing the informed consent and divided them into four dosage groups( 4 mg, 8 mg, 12 mg and 16 mg) random.In each group the dosage was the lower limbs partly intramuscular injection following the feeding artery in experimental stage Dl and D15. The plasma samples were collected to determine the HGF concentration in Dl ( before administration), D8, D15 ( before administration) , D21, D59, and the HGF-antibody concentration in Dl, D15, D28, D59, D91. Results (1)The concentrations of HGF in the subjects ranged from 216 pg/mL to 1189.75 pg/mL.(2) HGF-antibodies were not dectected in the subjects' plasma. Conclusions After using recombinant human HGF naked plasmid through intramuscular injection, the concentration of HGF expression product in subjects' peripheral blood does not have abnormally changed and using the drug the human body immune response does not generate.
4.In vitro experimental study of killing Hep-2 cells of laryngeal cancer with suicide fusion gene CDglyTK.
Yaoyun TANG ; Changning XIE ; Jianping LIU ; Suping ZHAO ; Yongquan TIAN ; Jianyun XIAO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2007;21(12):555-558
OBJECTIVE:
To study the killing effect of suicide gene CDglyTK combined with GCV or 5-FC on the human laryngeal carcinoma Hep-2 cell line in vitro.
METHOD:
Constructed plasmid pcDNA3.1 (-) CMV. CDglyTK was verified by enzyme digestion of Xho I /Hind III and automatic sequence analysis, then it was introduced into Hep-2 cells by electroporation to yield cells expressing CDglyTK stably after selecting with G418(400 ng/L) for 14 da. The expression of CDglyTK mRNA in transfected Hep-2 cells was tested by RT-PCR. Compared with Hep-2 cells transferred with pcDNA3.1(-), in vitro chemosensitivity of CDglyTK-expressing Hep-2 cells to 5-FC, GCV or 5-FC + GCV was detected by MTT assay.
RESULT:
The recombinant plasmid contained full-length coding region sequence of CD and TK gene. A anticipated 707 bp fragment was amplified from total RNA of CDglyTK-expressing Hep-2 cells by RT-PCR and a fusion protein of 59 000 was detected in cell extract from transfected Hep-2 cells. In vitro study growth of CDglyTK-positive Hep-2 cells were inhibited by 5-FC, GCV or 5-FC + GCV respectively, and the antitumour effect of 5-FC + GCV is superior to 5-FC or GCV.
CONCLUSION
CDglyTK may be a candidate for treating human laryngeal cancer.
Cell Line, Tumor
;
Cytosine Deaminase
;
genetics
;
Genes, Transgenic, Suicide
;
genetics
;
Genetic Therapy
;
Genetic Vectors
;
Humans
;
Laryngeal Neoplasms
;
genetics
;
Plasmids
;
Recombinant Fusion Proteins
;
genetics
;
Thymidine Kinase
;
genetics
5.The efficacy and safety comparison of transperitoneal laparoscopic adrenalectomy and retroperitoneal laparoscopic adrenalectomy for adrenocortical carcinoma
Kan WU ; Fan ZHANG ; Fuxun ZHANG ; Yongquan TANG ; Jiayu LIANG ; Liang ZHOU ; Sikui SHEN ; Zhihong LIU ; Yuchun ZHU
Chinese Journal of Urology 2022;43(11):830-834
Objective:To compare the efficacy and safety of retroperitoneal laparoscopic adrenalectomy (RLA) and transperitoneal laparoscopic adrenalectomy (TLA) in the treatment of localized adrenocortical carcinoma (ACC).Methods:The data of 22 patients with stage Ⅰ/Ⅱ ACC underwent laparoscopic adrenalectomy in our institution from January 2009 to December 2018 were retrospectively analyzed. According to the different surgical approaches, these patients were divided into RLA and TLA groups. Eleven patients underwent RLA and 11 patients underwent TLA. There were no significant differences between the RLA group and the TLA group in terms of age at first diagnosis[44 (35, 54) vs. 46(41, 55) years, P= 0.793], sex (male/female: 3/8 vs. 4/7, P = 1.00), secreting tumor ratio (3/11 vs. 4/11, P = 1.00), tumor location (left/right: 6/6 vs. 7/4, P = 1.00), with hypertension or diabetes mellitus (4/11 vs. 3/11, P = 1.00). However, RLA has significantly smaller tumor size [3.0(2.5, 8.4) cm vs. 7.7(5.2, 8.4)cm, P= 0.001], and more stage Ⅰ patients [90.9%(10/11) vs. 18.2%(2/11), P=0.002], compared with those in TLA group. The perioperative indicators and oncology prognosis outcomes were collected and compared between the two groups. The Kaplan-Meier method was performed to calculate the overall survival (OS) and disease-free survival (DFS). Results:Compared with TLA, RLA had shorter operation time[90(70, 100) vs. 110 (90, 120) min, P = 0.005] and postoperative drainage tube removal time [2 (2, 3) vs. 3 (2, 6) day, P = 0.002), and the difference was statistically significant. In the TLA group, one patient was converted to open operation due to intraoperative tumor capsule rupture. For postoperative complications, one patient in the TLA group suffered with wound infection. There were no perioperative deaths in either group. All postoperative pathological examinations confirmed ACC, and there was no significant difference in Ki-67 index between the two groups [10%(3%, 35%) vs. 10%(9%, 25%), P = 0.484]. The median follow-up was similar in the two groups [48(26, 98) vs. 31(18, 49) months, P=0.237]. The local recurrence and metastasis rates were 36.4% for RLA group and 63.6% for TLA group ( P = 0.395). Survival analysis showed no statistically significant difference in DFS [5-year DFS rate: 33.6% vs. 73.2%, P = 0.118] between the two groups. The 5-year OS rates for RLA group versus TLA group were 58.3% vs. 45.5% ( P=0.485). Conclusions:For localized (stage Ⅰ/Ⅱ) ACC, both RLA and TLA seem safe and feasible, based on the similar long-term oncological prognosis. However, compared with TLA, RLA has the advantage of shorter operation time and postoperative drainage tube removal time. Due to the small number of cases included in this study, further multi-center, large-sample studies are required to demonstrate clear benefit of one surgical approach in the future.
6. Chinese Integrated Guideline on Clinical Management of Gastric Precancerous Conditions and Lesions
Xudong TANG ; Yongquan SHI ; Shutian ZHANG ; Jie CHEN ; Junxiang LI
Chinese Journal of Gastroenterology 2021;26(2):91-111
Standardized diagnosis and effective treatment of gastric precancerous conditions and lesions are of great importance in preventing gastric cancer. This guideline was developed by five associations of traditional Chinese medicine and Western medicine based on the current status of prevalence, clinical diagnosis and treatment, integrating the Western medicine and traditional Chinese medicine with multidisciplinary participation, to provide targeted suggestions about essentials and strategies from the definition, epidemiology, diagnosis, staging, surveillance, treatment and evaluation of gastric precancerous conditions and lesions. It may play a guidance role in standardized diagnosis and treatment of gastric precancerous conditions and lesions and achieving effective secondary prevention of gastric cancer.